Evidence map›Paper›PMID 27920294›Full record

ArticleJournal of bacteriology2017

Effects of Increasing the Affinity of CarD for RNA Polymerase on Mycobacterium tuberculosis Growth, rRNA Transcription, and Virulence.

Ashley L Garner, Jayan Rammohan, Jeremy P Huynh, Lucas M Onder, James Chen, Brian Bae, Drake Jensen, Leslie A Weiss, Ana Ruiz Manzano, Seth A Darst and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. CarD contributes to diverse gene expression outcomes throughout the genome ofProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Ashley L GarnerDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Jayan RammohanDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, USA.
Jeremy P HuynhDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Lucas M OnderDepartment of Genetics and Waksman Institute of Microbiology, Rutgers University, Piscataway, New Jersey, USA.
James ChenLaboratory of Molecular Biophysics, The Rockefeller University, New York, New York, USA.
Brian BaeLaboratory of Molecular Biophysics, The Rockefeller University, New York, New York, USA.
Drake JensenDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, USA.
Leslie A WeissDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Ana Ruiz ManzanoDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, USA.
Seth A DarstLaboratory of Molecular Biophysics, The Rockefeller University, New York, New York, USA.
Elizabeth A CampbellLaboratory of Molecular Biophysics, The Rockefeller University, New York, New York, USA.
Bryce E NickelsDepartment of Genetics and Waksman Institute of Microbiology, Rutgers University, Piscataway, New Jersey, USA.
Eric A GalburtDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, USA.
Christina L StallingsDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA stallings@wustl.edu.
Washington University in St. Louis · USRockefeller University · USRutgers, The State University of New Jersey · US

Funding

TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
Transcription: Mechanism and RegulationR35GM118059 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI NICKELS, BRYCE EDWARD · 2016 to 2025
$7.1M
Structure/function analyses of essential mycobacterial transcription regulatorsR01GM114450 · NIGMS · ROCKEFELLER UNIVERSITY · PI CAMPBELL, ELIZABETH A · 2015 to 2023
$3.4M
INVESTIGATING NOVEL MECHANISMS OF TRANSCRIPTION INITIATION REGULATION IN MYCOBACTERIAR01GM107544 · NIGMS · WASHINGTON UNIVERSITY · PI GALBURT, ERIC A, STALLINGS, CHRISTINA LEIGH · 2013 to 2017
$1.5M
NIGMS NIH HHS R01 GM107544NIGMS NIH HHS R01 GM114450NIGMS NIH HHS R35 GM118059NIGMS NIH HHS T32 GM007067
6 · The paper itself

Abstract

CarD is an essential RNA polymerase (RNAP) interacting protein in Mycobacterium tuberculosis that stimulates formation of RNAP-promoter open complexes. CarD plays a complex role in M. tuberculosis growth and virulence that is not fully understood. Therefore, to gain further insight into the role of CarD in M. tuberculosis growth and virulence, we determined the effect of increasing the affinity of CarD for RNAP. Using site-directed mutagenesis guided by crystal structures of CarD bound to RNAP, we identified amino acid substitutions that increase the affinity of CarD for RNAP. Using these substitutions, we show that increasing the affinity of CarD for RNAP increases the stability of the CarD protein in M. tuberculosis In addition, we show that increasing the affinity of CarD for RNAP increases the growth rate in M. tuberculosis without affecting 16S rRNA levels. We further show that increasing the affinity of CarD for RNAP reduces M. tuberculosis virulence in a mouse model of infection despite the improved growth rate in vitro Our findings suggest that the CarD-RNAP interaction protects CarD from proteolytic degradation in M. tuberculosis, establish that growth rate and rRNA levels can be uncoupled in M. tuberculosis and demonstrate that the strength of the CarD-RNAP interaction has been finely tuned to optimize virulence. IMPORTANCE: Mycobacterium tuberculosis, the causative agent of tuberculosis, remains a major global health problem. In order to develop new strategies to battle this pathogen, we must gain a better understanding of the molecular processes involved in its survival and pathogenesis. We have previously identified CarD as an essential transcriptional regulator in mycobacteria. In this study, we detail the effects of increasing the affinity of CarD for RNAP on transcriptional regulation, CarD protein stability, and virulence. These studies expand our understanding of the global transcription regulator CarD, provide insight into how CarD activity is regulated, and broaden our understanding of prokaryotic transcription.

Indexed as

Amino Acid SequenceBacterial ProteinsDNA-Directed RNA PolymerasesGene Expression Regulation, BacterialGene Expression Regulation, EnzymologicModels, MolecularMycobacterium tuberculosisProtein BindingRNA, RibosomalTranscription, GeneticVirulenceBacterial ProteinsDNA-Directed RNA PolymerasesRNA, RibosomalMycobacterium tuberculosisprotein-protein interactionsprotein stabilityRNA polymeraserRNAtranscription initiation factor

Identifiers

PMID27920294
PMCPMC5287406
OpenAlexW2560522998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.